Sarepta Therapeutics
SRPT
#2385
Rank
โ‚น506.17 B
Marketcap
โ‚น5,152
Share price
0.13%
Change (1 day)
-52.07%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Earnings for Sarepta Therapeutics (SRPT)

Earnings in 2024 (TTM): โ‚น22.16 Billion

According to Sarepta Therapeutics 's latest financial reports the company's current earnings are โ‚น1.90 Billion. , an increase over its 2023 earnings that were of -โ‚น43.98 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sarepta Therapeutics from 1997 to 2024

Annual earnings

Year Earnings Change
2024 โ‚น22.04 B-150.14%
2023 -โ‚น43.98 Billion-24.62%
2022 -โ‚น58.34 Billion64.69%
2021 -โ‚น35.43 Billion-24.25%
2020 -โ‚น46.77 Billion-22.53%
2019 -โ‚น60.36 Billion96.87%
2018 -โ‚น30.66 Billion645.68%
2017 -โ‚น4.12 Billion-81.81%
2016 -โ‚น22.6 Billion21.47%
2015 -โ‚น18.61 Billion62.04%
2014 -โ‚น11.49 Billion21.26%
2013 -โ‚น9.47 Billion60.93%
2012 -โ‚น5.89 Billion93.69%
2011 -โ‚น3.04 Billion71.58%
2010 -โ‚น1.78 Billion35.06%
2009 -โ‚น1.32 Billion-11.62%
2008 -โ‚น1.49 Billion-47.02%
2007 -โ‚น2.8 Billion0.38%
2006 -โ‚น2.79 Billion88.3%
2005 -โ‚น1.49 Billion-30.06%
2004 -โ‚น2.12 Billion32.69%
2003 -โ‚น1.6 Billion-25.52%
2002 -โ‚น2.15 Billion64.52%
2001 -โ‚น1.31 Billion50.4%
2000 -โ‚น0.87 Billion26.44%
1999 -โ‚น0.69 Billion8%
1998 -โ‚น0.64 Billion102.7%
1997 -โ‚น0.32 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚น58.33 B 164.60%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น13.24 Billion-160.03%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น27.26 Billion-223.59%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น7.36 Billion-133.34%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น19.92 Billion-190.31%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น30.71 Billion-239.25%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น70.16 Billion-418.21%๐Ÿ‡บ๐Ÿ‡ธ USA